Search Results - "Dolores Martín‐Arranz, M."
-
1
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents
Published in Journal of gastroenterology and hepatology (01-12-2020)“…Background and Aim Biological therapies may be changing the natural history of inflammatory bowel diseases (IBDs), reducing the need for surgical intervention…”
Get full text
Journal Article -
2
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry
Published in Journal of Crohn's and colitis (14-07-2022)“…Abstract Background and Aims Immunomediated adverse events [IAEs] are the most frequently reported infliximab [IFX]-related adverse events. Combination therapy…”
Get full text
Journal Article -
3
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
Published in Gastroenterología y Hepatología (English Edition) (01-05-2024)“…The treatment of inflammatory bowel disease has undergone a significant transformation following the introduction of biologic drugs. Thanks to these drugs,…”
Get full text
Journal Article